The Real-world Effect of Long-acting Injectable Antipsychotics on Annual Medical Costs of Korean Schizophrenia Patients
Although the use of LAIs did not significantly lower the first-year medical costs of schizophrenia patients, they offer beneficial economic impacts over time by reducing hospitalization-associated costs. Future research should focus on long-term cost analyses and the impacts of newer LAI formulations.
Authors
- Hyun‐Ghang Jeong (ORCID: https://orcid.org/0000-0002-0318-5069)
- SuHyuk Chi (ORCID: https://orcid.org/0000-0002-4977-6200)
- Moon‐Soo Lee (ORCID: https://orcid.org/0000-0003-0729-6943)
- Jeong-Kyung Ko (ORCID: https://orcid.org/0000-0003-1525-337X)
Institutions
- Korea University Medical Center (KR)
Publication Details
- Journal
- Clinical Psychopharmacology and Neuroscience
- Published
- 2024-10-18
- DOI
- https://doi.org/10.9758/cpn.24.1206
- Citations
- 1
- Primary Topic
- Health Systems, Economic Evaluations, Quality of Life
- Type
- article
- Field-Weighted Citation Impact
- 1.13